Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2

References

1. ChakrabortiS., PrabakaranP., XiaoX., DimitrovD. S.2005; The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization. Virol J 2:73[CrossRef]
   [Google Scholar]
2. ChappleS. D., JonesI. M.2002; Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor. J Biotechnol 95:269–275[CrossRef]
   [Google Scholar]
3. ChenH., XuX., JonesI. M.2007; Immunogenicity of the outer domain of a HIV-1 clade C gp120. Retrovirology 4:33[CrossRef]
   [Google Scholar]
4. DrostenC., GuntherS., PreiserW., van der WerfS., BrodtH. R., BeckerS., RabenauH., PanningM., KolesnikovaL.other authors2003; Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967–1976[CrossRef]
   [Google Scholar]
5. FengY., GaoG. F.2007; Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus. Comp Immunol Microbiol Infect Dis 30:309–327[CrossRef]
   [Google Scholar]
6. GuyJ. L., JacksonR. M., JensenH. A., HooperN. M., TurnerA. J.2005; Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J 272:3512–3520[CrossRef]
   [Google Scholar]
7. HofmannH., PyrcK., van der HoekL., GeierM., BerkhoutB., PohlmannS.2005; Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102:7988–7993[CrossRef]
   [Google Scholar]
8. HofmannH., SimmonsG., RennekampA. J., ChaipanC., GrambergT., HeckE., GeierM., WegeleA., MarziA.other authors2006; Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol 80:8639–8652[CrossRef]
   [Google Scholar]
9. HuangI. C., BoschB. J., LiF., LiW., LeeK. H., GhiranS., VasilievaN., DermodyT. S., HarrisonS. C.other authors2006; SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281:3198–3203[CrossRef]
   [Google Scholar]
10. ImaiY., KubaK., RaoS., HuanY., GuoF., GuanB., YangP., SaraoR., WadaT.other authors2005; Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112–116[CrossRef]
    [Google Scholar]
11. KubaK., ImaiY., RaoS., GaoH., GuoF., GuanB., HuanY., YangP., ZhangY.other authors2005; A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11:875–879[CrossRef]
    [Google Scholar]
12. KuikenT., FouchierR. A., SchuttenM., RimmelzwaanG. F., van AmerongenG., van RielD., LamanJ. D., de JongT., van DoornumG.other authors2003; Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263–270[CrossRef]
    [Google Scholar]
13. LiW., MooreM. J., VasilievaN., SuiJ., WongS. K., BerneM. A., SomasundaranM., SullivanJ. L., LuzuriagaK.other authors2003; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454[CrossRef]
    [Google Scholar]
14. LiF., LiW., FarzanM., HarrisonS. C.2005a; Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864–1868[CrossRef]
    [Google Scholar]
15. LiW., ZhangC., SuiJ., KuhnJ. H., MooreM. J., LuoS., WongS. K., HuangI. C., XuK.other authors2005b; Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24:1634–1643[CrossRef]
    [Google Scholar]
16. LiW., SuiJ., HuangI. C., KuhnJ. H., RadoshitzkyS. R., MarascoW. A., ChoeH., FarzanM.2007; The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 367:367–374[CrossRef]
    [Google Scholar]
17. LinH. X., FengY., WongG., WangL., LiB., ZhaoX., LiY., SmaillF., ZhangC.2008; Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. J Gen Virol 89:1015–1024[CrossRef]
    [Google Scholar]
18. MarziA., GrambergT., SimmonsG., MollerP., RennekampA. J., KrumbiegelM., GeierM., EisemannJ., TurzaN.other authors2004; DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 78:12090–12095[CrossRef]
    [Google Scholar]
19. PyrcK., BerkhoutB., van der HoekL.2007; The novel human coronaviruses NL63 and HKU1. J Virol 81:3051–3057[CrossRef]
    [Google Scholar]
20. SlootsT. P., WhileyD. M., LambertS. B., NissenM. D.2008; Emerging respiratory agents: new viruses for old diseases?. J Clin Virol 42:233–243[CrossRef]
    [Google Scholar]
21. TowlerP., StakerB., PrasadS. G., MenonS., TangJ., ParsonsT., RyanD., FisherM., WilliamsD.other authors2004; ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279:17996–18007[CrossRef]
    [Google Scholar]
22. van der HoekL.2007; Human coronaviruses: what do they cause?. Antivir Ther 12:651–658
    [Google Scholar]
23. van der HoekL., PyrcK., JebbinkM. F., Vermeulen-OostW., BerkhoutR. J., WolthersK. C., Wertheim-van DillenP. M., KaandorpJ., SpaargarenJ., BerkhoutB.2004; Identification of a new human coronavirus. Nat Med 10:368–373[CrossRef]
    [Google Scholar]
24. van der HoekL., SureK., IhorstG., StangA., PyrcK., JebbinkM. F., PetersenG., ForsterJ., BerkhoutB., UberlaK.2005; Croup is associated with the novel coronavirus NL63. PLoS Med 2:e240[CrossRef]
    [Google Scholar]
25. WuP. S., ChangL. Y., BerkhoutB., van der HoekL., LuC. Y., KaoC. L., LeeP. I., ShaoP. L., LeeC. Y.other authors2008; Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr 167:75–80[CrossRef]
    [Google Scholar]